ACI-35.030 Tau Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ACI-35.030 Tau Vaccine, covering 2025-02-14 to 2025-02-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Immunogenicity of Tau Targeted Vaccines in Participants With Early Alzheimer's Disease [Phase 1, Phase 2]